Medical Oncology

Papers
(The H4-Index of Medical Oncology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Cancer induced bone pain: current management and future perspectives43
Cancer stem cell characteristics and their potential as therapeutic targets42
Vaccination of cancer patients against COVID-19: towards the end of a dilemma41
Effects of electroporation on anticancer activity of 5-FU and newly synthesized zinc(II) complex in chemotherapy-resistance human brain tumor cells32
The CXCL12/CXCR7 signalling axis promotes proliferation and metastasis in cervical cancer27
Correction to: The role of the WNT signaling pathway in the maxillary sinus squamous cell carcinoma26
Immune microenvironment-related gene mapping predicts immunochemotherapy response and prognosis in diffuse large B-cell lymphoma25
Resistin increases cisplatin-induced cytotoxicity in lung adenocarcinoma A549 cells via a mitochondria-mediated pathway22
The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies22
Metabolic shift of chronic myeloid leukemia patients under imatinib–pioglitazone regimen and discontinuation21
Identification of the dominant angiogenic CXCL class chemokines associated with non-small cell lung cancer via bioinformatics tools20
Identification of key genes in the tumor microenvironment of lung adenocarcinoma19
Combination of resveratrol and BIBR1532 inhibits proliferation of colon cancer cells by repressing expression of LncRNAs19
Computational study on novel natural inhibitors targeting BCL219
Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in regard to Triggiani et al.18
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance17
Systematic identification of the cancer pathways and molecules related with breast cancer immunogenicity17
0.022079944610596